AI, Nanobiotechnology, and the Future of Precision Antibiotics - Couverture souple

Couverture souple

ISBN 13 : 9798337352695

Editeur : Medical Information Science Reference, 2026

Synopsis

Antimicrobial resistance has become a defining global health emergency, eroding the effectiveness of existing therapies and placing millions of lives at risk as pathogens evolve faster than conventional drug development can respond. The scale and speed of this crisis expose fundamental limitations in traditional antibiotic discovery, which remains costly, slow, and poorly aligned with the biological complexity of infections. Advances in artificial intelligence (AI) offer the ability to rapidly explore vast chemical spaces and uncover novel antibacterial strategies, while nanobiotechnology enables precise delivery systems that can uncover biological barriers and reduce toxicity. When combined, these approaches open the door to precision antibiotics. Developing and integrating these technologies is therefore not optional but essential to restoring humanity's ability to control infectious diseases. AI, Nanobiotechnology, and the Future of Precision Antibiotics addresses the escalating global challenge of antimicrobial resistance, which continues to undermine the effectiveness of existing therapies and place growing pressure on healthcare systems worldwide. This volume presents an integrative perspective that brings together computational modeling, nanoscale engineering, and biologically informed therapeutic design within a unified conceptual framework. It highlights the convergence of these domains as a pathway toward more adaptive and effective antimicrobial solutions. Covering key topics such as antimicrobial therapies, nanocarrier technologies, and predictive modeling, this book serves as a valuable resource for researchers, clinicians, engineers, and policy-oriented scholars working across AI, nanomedicine, antimicrobial research, and global health innovation.

A propos du livre

À propos de l'auteur

Reyed M. Reyed is an Associate Professor of Microbial Biotechnology at the Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), Egypt, and serves as the Editor of . His research operates at the convergence of microbial biotechnology, artificial intelligence, and nanobiological systems, with a focus on advancing next-generation antimicrobial strategies. His work integrates microbiome science, computational modeling, and nanotechnology to address antimicrobial resistance through precision-driven approaches. Dr. Reyed has an established international publication record, contributing to edited volumes and scholarly works with leading academic publishers, including Springer Nature, IGI Global, Bentham Science, and Nova Science Publishers. He is the developer of Polybiome Systems Medicine and the originator of the Reyed Precision Convergence Framework for Antimicrobial Resistance (RPCF-AMR). Through these contributions, his work is positioned within the emerging paradigm of precision antibiotics, where data-driven intelligence and multiscale biological integration shape the future of antimicrobial innovation and targeted therapeutic development..

Détails de l'édition

• Éditeur: Medical Information Science Reference
• Date d'édition: 2026
• Langue: anglais
• ISBN 13: 9798337352695
• Reliure: Tapa blanda
• Nombre de pages: 488
• Éditeur: Reyed Reyed M.
• Coordonnées du fabricant: non disponible
• Personne responsable: GPSR Kontakt; gpsr@libri.de; ; Europaallee 1; Bad Hersfeld; 36244; Allemagne